Delivering Early Phase Confidence Through Expertise and Experience - Celerion collaborates with emerging and established Pharmaceutical and Biotechnology companies during the pathway for drug approval, with rapid and safe progression to Clinical Proof-of-Concept.
Services:Early Phase Services - With 40 years of experience and more than 600 beds in North America and Europe, we offer the largest and most experienced global early phase clinical operations in the industry. Phase 2-3 Services - Celerion is well-positioned to adapt to the ever increasing complexity of clinical trials. We identify challenges in the earliest stages of development and are well prepared to take your study to its full potential. Further services include Bioanalytical and DMB.